Famor, Yollimae .

HRN: 29-14-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/14/2026
06/20/2026
IV
900mg
Q8
T/c Chorioamnionitis
Checking Initial Appropriateness 
06/14/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/14/2026
06/20/2026
IV
900mg
Q8
Amnionitis/ Foul Smelly Thickly MSAF
Checking Initial Appropriateness 
06/14/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
06/14/2026
06/20/2026
IV
240mg
Od
Amnionitis/foul Smelly Thickly MSAF
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: